TSX VENTURE COMPANIES
BULLETIN V2026-2696
EVERKIND WELLNESS INC. ("EK")
[formerly, AF2 CAPITAL CORP. ("AF.P")]
BULLETIN TYPE: Qualifying Transaction-Completed/New Symbol; Name Change and Consolidation, Resume Trading
BULLETIN DATE: August 24, 2026
TSX Venture Tier 2 Company
TSX Venture Exchange has accepted for filing the Qualifying Transaction (the "Transaction") of Everkind Wellness Inc. (formerly, AF2 Capital Corp.) (the "Company") described in its information circular dated March 12, 2026 (the "Information Circular") and in the press release dated May 15, 2026.
As a result, at the opening on August 26, 2026, AF2 Capital Corp. will no longer be considered as a Capital Pool Company.
The Qualifying Transaction consisted of the arm's length acquisition of all of the issued and outstanding common shares in the capital of Everkind Inc. ("Everkind") pursuant to the amalgamation agreement dated March 12, 2026, as amended May 15, 2026 (the "Amalgamation Agreement") in exchange for 92,960,749 post-consolidated shares (excluding the concurrent financing shares) at a deemed value of $0.80 per share.
The Company consolidated its shares on a 1 new for 5.33333 old share basis (the "Consolidation"). The shares will be exchanged on a 1 for 1 basis on a post-Consolidation basis.
For additional information, refer to the Company's press releases dated March 12, 2026, May 15, 2026, August 19, 2026, August 21, 2026, and its Information Circular dated March 12, 2026 which are filed on SEDAR+.
Prior to the completion of the QT, Everkind completed the concurrent Non-Brokered Private Placement of 7,625,000 subscription receipts at $0.80 per subscription receipt to raise aggregate gross proceeds of $6,100,000. The subscription receipts were converted into common shares of Everkind which were exchanged for post-Consolidation securities of the Company.
Name Change and Consolidation
Pursuant to a resolution passed by the Company's directors on July 31, 2026, the Company consolidated its capital on a (5.33333) old for (1) new basis. The name of the Company has also been changed as detailed below.
Effective at the opening August 26, 2026, the common shares of Everkind Wellness Inc. will commence trading on TSX Venture Exchange, and the common shares of AF2 Capital Corp. will be delisted.
Resume Trading
Effective at the opening of business on August 26, 2026, the Common Shares of Everkind Wellness Inc. will commence trading on the TSX Venture Exchange as a Tier 2 Technology company.
Capitalization: Unlimited number of Common Shares with no par value of which 101,523,249 Common Shares are issued and outstanding.
Escrow: 27,073,089 Common Shares, issued pursuant to the Qualifying Transaction are escrowed pursuant to an Exchange Tier 2 Escrow Agreement
Transfer Agent: Endeavor Trust Corporation
Trading Symbol: EK (NEW)
CUSIP Number: 30036E104 (NEW)
The Exchange has been advised that the above transactions have been completed.
Company Contact: Jonathan Held
Company Address: 301-217 Queen St. W, Toronto, ON, M5V 0R2
Company Phone Number: 647-366-2795
Company e-mail address: investors@everkind.com
Company website address: www.everkind.com
_______________________________________
|
|
